Page last updated: 2024-08-23

dianhydrogalactitol and Astrocytoma, Grade IV

dianhydrogalactitol has been researched along with Astrocytoma, Grade IV in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Al-Shahrour, F; Curiel-García, Á; Galán-Ganga, M; Jiménez-Alcázar, M; Lowe, SW; Nogales, P; Perales-Patón, J; Schuhmacher, AJ; Squatrito, M; Zhu, L1
Fu, X; Huang, C; Huang, Y; Jiang, X; Li, F; Li, Y; Liang, Q; Liu, H; Wang, X1
Espana, P; Walker, MD; Wiernik, PH1
Bisel, HF; Childs, DS; Eagan, RT; Fleming, TR; Holbrook, MA; Laws, ER; Layton, DD1

Trials

2 trial(s) available for dianhydrogalactitol and Astrocytoma, Grade IV

ArticleYear
Phase II study of dianhydrogalactitol in malignant glioma.
    Cancer treatment reports, 1978, Volume: 62, Issue:8

    Topics: Adult; Aged; Clinical Trials as Topic; Dianhydrogalactitol; Drug Evaluation; Glioblastoma; Humans; Leukopenia; Middle Aged; Sugar Alcohols

1978
Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
    JAMA, 1979, May-11, Volume: 241, Issue:19

    Topics: Adult; Aged; Brain Neoplasms; Dianhydrogalactitol; Female; Glioblastoma; Humans; Leukopenia; Male; Middle Aged; Sugar Alcohols

1979

Other Studies

2 other study(ies) available for dianhydrogalactitol and Astrocytoma, Grade IV

ArticleYear
Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma.
    Molecular cancer therapeutics, 2021, Volume: 20, Issue:6

    Topics: Animals; Cell Line, Tumor; Dianhydrogalactitol; Drug Resistance, Neoplasm; Glioblastoma; Humans; Mice; Temozolomide; Transfection; Xenograft Model Antitumor Assays

2021
Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dianhydrogalactitol; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neovascularization, Pathologic; Proto-Oncogene Proteins; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Zebrafish

2017